Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients

Granulomatous lymphocytic interstitial lung disease (GLILD) represents a fatal immune dysregulatory complication in common variable immunodeficiency (CVID). Evidence-based diagnostic guidelines are lacking, and GLILD treatment consists in immunosuppressive drugs; nonetheless, therapeutical strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tessarin, Giulio, Baronio, Manuela, Gazzurelli, Luisa, Rossi, Stefano, Chiarini, Marco, Moratto, Daniele, Giliani, Silvia Clara, Bondioni, Maria Pia, Badolato, Raffaele, Lougaris, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661825/
https://www.ncbi.nlm.nih.gov/pubmed/37755605
http://dx.doi.org/10.1007/s10875-023-01587-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661825/
https://www.ncbi.nlm.nih.gov/pubmed/37755605
http://dx.doi.org/10.1007/s10875-023-01587-4

Ejemplares similares